Navigation Links
PharmaCM CT 2.0 to Help Pharma Manage Multinational Registries
Date:8/20/2013

NEW YORK, Aug. 20, 2013 /PRNewswire/ -- With the life sciences R&D industry undergoing a "major shift around modernization," Deloitte Analytics LLC is releasing PharmaCM CT 2.0, a solution that gives pharmaceutical and biotech companies one system for managing the clinical trial application process in both the United States and Europe.

PharmaCM CT 2.0 automates much of the activity involved in initiating clinical trials on the U.S. and European registries and in complying with ongoing disclosure and publishing requirements. It's an upgrade from PharmaCM CT 1.0 in that it supports the European Clinical Trial Database (EudraCT) in addition to its U.S. counterpart, ClinicalTrials.gov.

"Today's pharma and biotech companies play on a global stage, so they need solutions that do the same," said Thomas Wicks, general manager, Deloitte Analytics LLC and PharmaCM business leader. "Using a single platform to manage more of a firm's global trial activity will reduce time training staff and doing manual procedures."

According to Matthew Hudes, managing principal, Deloitte Consulting LLP and leader of Deloitte's biotechnology industry practice, products like PharmaCM CT 2.0 reflect a broader transformation underway working to modernize the R&D process.

"One of the promising trends in life sciences today is how drug and device development is adopting innovative process improvements – techniques that have greatly enhanced productivity in other industries," said Hudes. "PharmaCM CT 2.0 is an example of how pharma and biotech may be able to utilize these capabilities to substantially improve the R&D process."

Wicks said PharmaCM CT 2.0's functionality includes managing disclosure workflows, accepting data from multiple sources and tracking compliance dates. He also noted that it's updated frequently to reflect regulatory changes.

"This solution harmonizes data across various registries and can significantly reduce the manual labor and IT resources needed in conducting clinical trials from a global perspective," said Wicks. 

Please visit www.pharmacm.com for more information or to schedule a product demonstration.

About Deloitte's Life Sciences and Health Care Practice
Deloitte's life sciences and health care practice brings fresh insight to clients and industry stakeholders. Deloitte offers a distinctive menu of professional services delivered in an integrated approach that address many segments of the health plan, health provider and life sciences industries. For more information, visit www.deloitte.com/view/en_US/us/Industries/index.htm

As used in this document, "Deloitte" means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.


'/>"/>
SOURCE Deloitte Analytics LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... 10, 2017  BDI Group subsidiary Pathway Purchasing ... services organization serving specialty pharmacies, home infusion companies ... four significant, value-added member programs designed to help ... reimbursement and improve access and affordability for patients ... Pathway has ...
(Date:7/6/2017)... 6, 2017 ThriveRx, the nutrition division of Diplomat Specialty Infusion ... thrive on nutrition support. To celebrate its anniversary, ThriveRx recently ... a fresh new look with improved organization to create the best user ... ... "We,ve made several ...
(Date:7/5/2017)... company of over 2,000 employees and a leader in environmental and life science ... their position as the top American owned and operated environmental testing firm in ... ... ... , enhances Pace Analytical,s capability as an innovative full service provider in ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... ... “Squiggy’s Outdoor Adventure”: a turtle’s backyard adventure that teaches the importance of ... Christian, a wife and mother to three amazing, and supportive, children. Paula lives ... God. She loves to tell stories to her children, play board games, bake, ...
(Date:7/22/2017)... ... July 22, 2017 , ... The arthroscopic superior ... the opportunity to return to sports and jobs that require heavy physical work, ... Medicine’s Annual Meeting in Toronto, Ontario, Canada. , “We studied 100 ...
(Date:7/21/2017)... Augusta, GA (PRWEB) , ... July 21, 2017 , ... ... is teaming up with the Epilepsy Foundation in a community wide charity event with ... region. , Delaney Sunde, a young local woman who lives with epilepsy, recently launched ...
(Date:7/21/2017)... ... , ... Fresh Wave® IAQ today announced the launch of its innovative ... at the APPA 2017 Annual Conference and Exhibition in Booth #414. , ... the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air & Fabric Liquid ...
(Date:7/21/2017)... ... ... Margarian Law Firm has filed a class action lawsuit against Dr. Pepper ... Dr. Pepper produces the “Canada Dry” brand of ginger ale products. In Gegham Margaryan ... claims on its bottle that it is made from real ginger. , When consumers ...
Breaking Medicine News(10 mins):